Printer Friendly

Understand How to Optimize Brand Lifecycle Management with Winning Strategies to Maximize Revenue in the Face of Growing Generic Competition.

DUBLIN, Ireland -- Research and Markets ( has announced the addition of the "Generic Series: Optimizing Brand Lifecycle Management Winning Strategies to Maximize Revenue in the Face of Growing Generic Competition" report to their offering.

As competitive pressures from the entry of generics post-patent expiry and new brands are growing, product lifecycles are evolving for the worst. Effective lifecycle management is becoming a must for Pharma looking to maximize their return on investment, regardless of which stage of the lifecycle a drugs is in. However such strategies are becoming most prominent immediately before patent expiry.


- Review of key reasons why lifecycle management is important now

- Analysis of key considerations Pharma need to take care of when devising lifecycle management strategies

- Discussion of most commonly used lifecycle management strategies

- Case study analysis of successful and unsuccessful lifecycle management strategies employed by Pharma

Highlights of this title

One of the key challenges for Pharma is the loss of corporate memory regarding specific brands as brand managers spend on average only 18 months on one product with mainly short term goals in mind. Pharma need to take a structured approach to lifecycle management with a regular review of their strategies in response to internal and external events.

Lifecycle management should not be left until only few years are left to patent expiry. Revenues can be maximized during launch and peak phases by employing the right approaches. If a company starts planning its lifecycle management strategy early, it has more strategies available. However, many companies leave planning until late in the lifecycle.

Payers and physicians are becoming more sceptical of certain steps taken by Pharma as they consider them to be pure lifecycle management. Follow-on products such as reformulations and fixed dose combinations need to ensure they truly satisfy an unmet need in order to achieve even moderate uptake.

Key reasons to purchase this title

- Identify critical considerations for creating the optimal lifecycle management plan

- Understand when the different lifecycle management strategies are most appropriate

- Gain insight into recent successful and unsuccessful lifecycle management strategies

Key Topics Covered:

- Introduction To Lifecycle Management

- Critical Considerations For Product Lifecycle Management

- Selecting The Right Lifecycle Management Strategy

- Case Studies Of Recent Lifecycle Management Strategies Used By Biopharma

- List Of Figures

- List Of Tables

For more information visit

Source: Datamonitor
COPYRIGHT 2008 Business Wire
No portion of this article can be reproduced without the express written permission from the copyright holder.
Copyright 2008 Gale, Cengage Learning. All rights reserved.

Article Details
Printer friendly Cite/link Email Feedback
Publication:Business Wire
Date:Sep 8, 2008
Previous Article:CA to Deliver Wide-Ranging Support for Microsoft Virtualization Products.
Next Article:Proposal Software, Inc. Introduces Revolutionary New Search Accelerator; Expanding Web-based Technologies and Adding 'Pitch Book' Functionality.

Related Articles
Telvista: imagine having a true customer care solutions advocate.
As Long as Brand Patents Continue to Expire, Pharmaceutical Companies Will Continue to Challenge Generic Entrants with 'New and Improved' Versions of...
Generic Cancer Market - New Legislation and a Wave of Patent Expiries to Transform the Market.
Developing end-of-lifecycle strategies.
Examine Key Factors Affecting Brand Erosion at Patent Expiry.
Automate the tactical--and optimize your product management processes.
Leveraging the retention lifecycle.

Terms of use | Privacy policy | Copyright © 2019 Farlex, Inc. | Feedback | For webmasters